Image source

The 5 largest licensed producers (LPs), as tracked in our munKNEE Canadian Cannabis LPs Index, are ranked below, in descending order, as to their:

• stock performances so far in April (i.e. MTD) and year-to-date (YTD),
• likelihood of Financial Distress within the next 2 years (according to data from macroaxis.com),
• average Wall Street analyst 12-month Price Targets (from SeekingAlpha.com),
• extent of Short Interest (the number of shorted shares divided by the number of shares outstanding),
• percentage of Insider Ownership (directors and senior officers or other beneficial holders with 10% or more of the common shares),
• percentage of Institutional Ownership, and
• current market capitalizations.

1. Tilray (TLRY): DOWN 2.4% MTD; Now DOWN 7.5% YTD
   • 22 analysts:
     • have an average 12-month price target representing a 76% increase from its current price and
     • have a consensus BUY rating.
   • In addition, TLRY has:
     • 68% chance of Financial Distress within 2 years,
     • 9% Short Interest,
     • 1.3% Insider Ownership,
     • 11.4% Institutional Ownership and
     • $1,560B in Market Capitalization.
   • Anheuser-Busch (BUD) has a $100 million joint venture with TLRY.
2. Cronos (CRON): DOWN 5.2% MTD; Now DOWN 27.0% YTD
   • 18 analysts:
     • have an average 12-month price target representing a 55% increase from its current price and
     • have a consensus BUY rating.
   • In addition, CRON has:
     • 2% chance of Financial Distress within 2 years,
     • 3.7% Short Interest,
     • 5.4% Insider Ownership,
     • 13.1% Institutional Ownership, and
     • $706M in Market Capitalization.
   • Altria Group (MO) has a 45% stake in CRON
3. Aurora (ACB): DOWN 7.1% MTD; Now DOWN 27.0% YTD
   • 14 analysts:
     • have an average 12-month price target representing a 151% increase from its current price and
     • have a consensus HOLD rating.
   • In addition, ACB has:
     • 78% chance of Financial Distress within 2 years,
     • 8.7% Short Interest,
     • 0.12% Insider Ownership,
     • 21.8% Institutional Ownership, and
     • $223M in Market Capitalization.
   • received a Nasdaq notice on March 27th that the company is no longer in compliance with the minimum bid price requirement as the price has been below $1.00 for a period of 30 consecutive business days and has been granted a period of 180 calendar days or until September 20, 2023 to regain compliance with the minimum bid price requirement.
4. OrganiGram (OGI): DOWN 7.8% in March; Now DOWN 24.3% YTD
   • 15 analysts:
     • have an average 12-month price target representing a 122% increase from its current price and
     • have a consensus BUY rating.
   • In addition, OGI has:
     • 49% chance of Financial Distress within 2 years,
     • 2.1% Short Interest,
     • 0.09% Insider Ownership,
     • 11.3% Institutional Ownership. and
     • $214 in Market Capitalization.
   • British American Tobacco (BTI) has invested C$221M in a product development partnership with OGI
5. Canopy Growth (CGC): DOWN 12.6% MTD; Now DOWN 32.6% YTD
   • 23 analysts:
     • have an average 12-month price target representing a 68% increase from its current price and
     • have a consensus SELL rating.
   • In addition, CGC has:
     • 53% chance of Financial Distress within 2 years,
     • 16.1% Short Interest,
     • 0.08% Insider Ownership,
     • 13.5% Institutional Ownership, and
     • $795M Market Capitalization.
   • Constellation Brands (STZ) has a 39% stake in CGC.

Summary

In total, the sum total of the above 5 constituents in the munKNEE Canadian Cannabis LPs Index have had an average price change of -6.3% MTD and are now -22.5% YTD and have an average 12-month price target representing a 79.5% increase from their current average prices.

More By This Author:

15 Gold And Silver Junior "Miners" With Parabolic Potential
Latest Gold Forecasts (11) Range From $3,000 To $10,000/ozt.
"Rags-To-Riches" Portfolio Down 8.6% In March; Now -3.9% YTD